RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:RainDance Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014372
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR system, an unified platform for NGS amplicon enrichment and digital PCR. RDT’s consumables include source chips, sense chips and oil surfactants. It also offers next-generation sequencing enrichment solutions, among others. The company serves academic and translational research institutions, pharmaceutical and biotechnology companies, agricultural and industrial clients, cancer centers, bio-banks, commercial laboratories, and government institutions. It distributes its products through a network of distributors across Asia Pacific and EMEA regions. RDT is headquartered in Billerica, Massachusetts, the US.

RainDance Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RainDance Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RainDance Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 11
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
RainDance Technologies Secures US$37.5 Million In Series D Financing 14
Partnerships 15
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 17
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 18
Asset Transactions 19
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 19
Acquisition 21
Bio-Rad Labs to Acquire RainDance Technologies 21
RainDance Technologies Inc – Key Competitors 22
RainDance Technologies Inc – Key Employees 23
RainDance Technologies Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Jun 29, 2016: RainDance Technologies Appoints Kathy Ordonez as Chief Executive Officer 25
Legal and Regulatory 26
Jan 20, 2017: 10x Genomics Invalidates RainDance Technologies Patent 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RainDance Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RainDance Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
RainDance Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 11
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
RainDance Technologies Secures US$37.5 Million In Series D Financing 14
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 17
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 18
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 19
Bio-Rad Labs to Acquire RainDance Technologies 21
RainDance Technologies Inc, Key Competitors 22
RainDance Technologies Inc, Key Employees 23

★海外企業調査レポート[RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • Forma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forma Therapeutics Inc (Forma) is a drug discovery and development company that discovers and develops new transformative cancer therapeutics. The company develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor met …
  • Bonvests Holdings Limited:戦略・SWOT・企業財務分析
    Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • UIL Energy Ltd (UIL):石油・ガス:M&Aディール及び事業提携情報
    Summary UIL Energy Ltd (UIL Energy) is an oil and gas company. The company provides business activities such as exploration for reserves of both conventional and unconventional oil and natural gas plays in proven hydrocarbon basins in Western Australia. It offers portfolio such as gas and liquids th …
  • Sebia SA:企業の製品パイプライン分析2018
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sanquin Blood Supply Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Comrod Communication ASA:企業の戦略・SWOT・財務情報
    Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report Summary Comrod Communication ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Showa Shell Sekiyu KK (5002):電力:M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • ICICI Prudential Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Bata India Limited:企業の戦略・SWOT・財務分析
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • TransMontaigne Product Services LLC:企業の戦略的SWOT分析
    TransMontaigne Product Services LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Rizal Commercial Banking Corp (RCB):電力:M&Aディール及び事業提携情報
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Worldpay Group Ltd:企業の戦略・SWOT・財務分析
    Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆